← FDA DRUG APPROVALS

FDA ANDA · ANDA072196

MILOPHENE

clomiphene citrate

Sponsor: GRANATA BIO CORP

APPLICATION
ANDA072196
TYPE
ANDA
ORIGINAL APPROVAL
1988-12-20
LATEST ACTION
2025-08-15
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

MILOPHENEPrescription
CLOMIPHENE CITRATE 50MG · TABLET · ORAL

Approval history

2025-08-15Manufacturing (CMC) · Supplement 8 · unknownAP
1998-01-23Manufacturing (CMC) · Supplement 1AP
1998-01-23Manufacturing (CMC) · Supplement 4AP
1998-01-23Manufacturing (CMC) · Supplement 2AP
1998-01-23Manufacturing (CMC) · Supplement 5AP
1998-01-23Labeling · Supplement 3AP
1988-12-20OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →